[widget id="nav_menu-11"][widget id="custom_html-3"]
The following industry-supported symposia, organized by ICNMD 2021 sponsors, were broadcast live during the 2021 Live Days. Click on the tabs below to read more.
You will find these symposia listed chronologically in the 'Symposia & Product Theatres' section of the virtual platform.
You may click directly on the dedicated symposium links below to be taken directly to each symposium page. You will need to log in with your platform credentials.
![]() |
ISS01 - gMG 360: Generalised myasthenia gravis from cause to consequence Time: 12:00 - 12:45 CEST Agenda
For more information, click here. |
![]() |
ISS02 - A Novel Assessment of Swallowing in SMA: Insights from the NURTURE Study Time: 12:00 - 12:20 CEST Agenda
For more information, click here. |
![]() |
ISS03 - Current Treatment Landscape of Myotonia in Muscle Channelopathies: Focus on Mexiletine Time: 12:25 - 12:45 CEST Agenda Speaker: Prof Savine Vicart, University Hospital Pitié-Salpêtrière, France
For more information, click here. |
![]() |
ISS04 - Gene Therapy – Transforming the Clinical Outlook for Neuromuscular Diseases Time: 17:15 - 18:00 CEST Agenda
For more information, click here. |
![]() |
ISS05 - How to Overcome Challenges in Pompe Disease Management During the COVID-19 Era Time: 17:15 - 18:00 CEST Agenda
For more information, click here. |
![]() |
ISS06 - Intrahepatic Cholestasis in X-linked Myotubular Myopathy Time: 12:00 - 12:45 CEST |
![]() |
ISS07 - Meaningful Outcomes Across All SMA Types Time: 12:00 - 12:45 CEST Agenda
For more information, click here. |
![]() |
ISS08 - Serum Autoantibody Levels and the Role of Specificity in Myasthenia Gravis Time: 16:15 - 17:00 CEST Agenda
For more information, click here. |
![]() |
ISS09 - Investigating Gene Therapy for the Treatment of Limb Girdle Muscular Dystrophies Time: 16:15 - 17:00 CEST Agenda
For more information, click here. |
![]() |
ISS10 - Can We Regain Control? A Clinical Case-Based Discussion on the Treatment of Refractory Generalized Myasthenia Gravis Time: 12:00 - 12:45 CEST Agenda
For more information, click here. |
![]() |
ISS11 - A Unique Pregnancy Case: Venturing Beyond the Norms in Pompe Disease Time: 12:00 - 12:20 CEST Agenda Speakers: Prof. Priya Kishnani, Professor of Pediatrics, Duke Department of Pediatrics, USA (chair & speaker)
For more information, click here. |
![]() |
ISS12 - What Matters? Setting Treatment Expectations for Motor Function in SMA Type 1 Time: 12:25 - 12:45 CEST Agenda
For more information, click here. |
![]() |
ISS13 - Understanding the Immunomodulatory Effects and Clinical Benefits of IVIG in Myasthenia Gravis Time: 16:15 - 17:00 CEST Agenda
For more information, click here. |
![]() |
ISS14 - Advancing the Management of Duchenne Muscular Dystrophy: The Disease Continuum and Transition from Pediatric to Adult Care Time: 16:15 - 17:00 CEST Agenda
For more information, click here. |
![]() |
ISS15 - Life and Death in the Neuron: the Role of the ER and Mitochondria in ALS Time: 12:00 - 12:45 CEST Agenda Speakers: Stephanie Hoffmann, Acting Head of EUMEA, Amylyx Pharmaceuticals (Chair)
For more information, click here. |
![]() |
ISS17 - Suspecting, Diagnosing, and Managing Multifocal Motor Neuropathy: A Patient Investigation Time: 17:15 - 18:00 CEST Agenda
For more information, click here. |
![]() |
ISS18 - Gene Transfer Therapy: Addressing the Unmet Needs of Duchenne Muscular Dystrophy (DMD) Time: 17:15 - 17:35 CEST Agenda Speaker: Professor Wolfgang Müller-Felber, Dr von Hauner Children’s Hospital, Germany
For more information, click here. |